Skip to main content
Rogelio Mosqueda-Garcia, MD, Internal Medicine, King Of Prussia, PA

RogelioMosqueda-GarciaMDPh.D.

Internal Medicine King Of Prussia, PA

Cardiology

VicePresident & Global Head ECD/Clinical Pharmacology

Dr. Mosqueda-Garcia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mosqueda-Garcia's full profile

Already have an account?

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 1987 - 2001
  • Vanderbilt University
    Vanderbilt University1987 - 1990
  • McGill University
    McGill UniversityPhD, Pharmacology, 1982 - 1986
  • McGill University, Montreal General Hospital
    McGill University, Montreal General HospitalInternal Medicine, 1982 - 1985
  • Universidad Nacional Autonoma de Mexico
    Universidad Nacional Autonoma de MexicoClass of 1982

Publications & Presentations

PubMed

Journal Articles

  • Role of CYP2C19 polymorphism in the pharmacokinetics of rosuvastatin in healthy Taiwanese subjects  
    Wang Y. Wang T-D, Finkelman R.D, Jou1 H-C, Azumaya C.T, Mosqueda-Garcia R,, Clin Pharmacol Drug Development, 2014
  • Apixaban, an oral, direct factor-Xa inhibitor: single-dose safety, pharmacokinetics, and pharmacodynamics  
    Frost C, Wang J, Nepal S, Schuster A, Chen Barrett Y, Reeves RA,, LaCreta F, Mosqueda-Garcia R, Bri J Clin Pharm. 2013;75:476-487, 2013
  • The elusive pathophysiology of neurally mediated syncope.  
    Mosqueda-Garcia R, Medina E, Fernandez-Violante R., Circulation, 2000
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Safety Evaluation in Clinical Pharmacology and Experimental Medicine Studies. Are Changes Needed?" 
    Thomas Jefferson University. School of Medicine - 12/9/2008
  • 36. Safety in Phase I; Changes & lessons from the Tegenero (TGN1412) Experience 
    AstraZeneca Clinical Pharmacology Series - 8/31/2006
  • The elusive pathophysiology of neurally mediated syncope 
    Hospital Sacco. Milan Italy - 6/18/1999
  • Join now to see all

Grant Support

  • Autonomic Cardiovascular Regulation. Central Sympathetic Dysfunction in Orthostatic IntoleranceNational Institutes of Health1997–2002
  • Mechanisms Of Antiarrhythmic Drug Action Supplement--Simulated MicrogravityNational Center For Research Resources1996
  • Central Sympathetic Activation In Cardiovascular Effects Of NicotineNational Center For Research Resources1994–1996
  • Specialized Center of Research in HypertensionNational Institutes of Health1990–1995
  • Neural Sympathetic Effects Of Ethanol In ManNational Center For Research Resources1992–1993
  • Reflex Control of the Circulation and Interaction with Glutamate in the BrainstemAmerican Heart Association1989–1990